Recent studies have demonstrated that PPAR agonists (PPARα and PPARγ) reduce body weight, ameliorate insulin resistance, induce the browning of beige adipocytes, enhance both UCP1‐dependent and independent thermogenesis, and improve mitochondrial metabolism in murine models (Miranda et al. 2024). The gene discussed is PPARA; the disease is Insulin resistance.